1072091-03-2

Upstream product

• 409095-87-0 ethyl (2S,3R)-3-formyl-2-(4-methoxyphenylamino)butanoate 
• 124156-21-4 ethyl (4-methoxyphenylimino)acetate 

Downstream Products

• 1072091-02-1 ethyl (3R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-(4-methoxyphenyl)-L-valinate 
• 1072091-09-8 N-[(1S,2E)-4-(benzyloxy)-1-((1R)-2-{[tert-butyl(dimethyl)silyl]oxy}-1-methylethyl)-2-methylbut-2-en-1-yl]-4-methoxyaniline 
• 1072091-11-2 C₂₁H₃₇NO₃Si 
• 1072091-04-3 (3R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-methoxy-N₂-(4-methoxyphenyl)-N-methyl-L-valinamide 
• 1072091-06-5 ethyl (2E,4S,5R)-6-{[tert-butyl(dimethyl)silyl]oxy}-4-[(4-methoxyphenyl)amino]-3,5-dimethylhex-2-enoate 
• 1072091-12-3 (2R,3S,4E)-6-(benzyloxy)-3-[(4-methoxyphenyl)amino]-2,4-dimethylhex-4-en-1-ol 

Relevant academic research and scientific papers

Enantioselective anti-Mannich reaction catalyzed by modularly designed organocatalysts

A highly stereoselective method for achieving the anti-Mannich reaction of aldehydes and ketones with ethyl (4-methoxyphenylimino)acetate was realized using the modularly designed organocatalysts (MDOs) self-assembled from cinchona alkaloid derivatives an

12 MEMBERED-RING MACROLACTAM DERIVATIVES

There provided a 12-membered-ring macrolactam derivative having antitumor activity: A compound represented by Formula (1) or a salt thereof. In this Formula, R1 is a hydrogen atom, a C1-6 alkyl group, a C1-6 alkylcarbonyl